Data on 12,359 type 2 diabetes patients with poor glucose control revealed those who showed A1C improvements were less likely to die of any cause within five years compared with those who had no improvement in glucose levels. Participants with improved A1C were also less likely than those with poor glycemic control to develop coronary heart disease and experience fatal cardiovascular disease, researchers noted. The results were presented at the European Association for the Study of Diabetes meeting.
A1C improvements curb 5-year mortality risk in diabetes
SmartBrief Job Listings for Health Care
|Chief Financial Officer||
B. E. Smith
Attest Health Care Advisors
|Biotechnology/Pharmaceutical Patent Attorney||
Coats and Bennett PLLC
|Sr. Regulatory Specialist, Biotech Center of Expertise||
BASF, The Chemical Co.
|San Diego, CA|